On August 27, 2019, Board of Phoenix Life Sciences International Limited permanently removed Martin Tindall as Chief Executive Officer and/or any other of its officer positions or that of its subsidiaries. On August 27, 2019, Board of Directors appointed the following Board Members to its Audit Committee, Compensation Committee, and Nominating Committee: Audit Committee: Lewis Humer, Geoff Boynton. Compensation Committee: Lewis Humer, Stephen Cornford and Nominating Committee: Lewis Humer, Janelle Marsden.